Stocks · News reference
US Stocks Mixed; Retail Sales Fall In July
US stocks mixed, Nasdaq up 0.2%. Retail sales down 0.6% in July. Wetour Robotics up 150%, while Innventure Inc drops 47%.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
MicroVision Partners with Kodiak AI to Integrate IRIS Lidar into Autonomous Trucks
MicroVision, Inc. has announced a partnership with Kodiak AI, Inc. to integrate its IRIS long-range lidar sensor into Kodiak's autonomous driving platform for commercial long-haul trucking.
MicroVision: 3 Key Takeaways for Long-Term Investors
MicroVision reported Q3 2026 revenue of $2.4 million and maintained full-year guidance of $10-15 million, driven by commercial LiDAR hardware shipments. The company cut headcount by 28% to reduce 2027 operating cash burn from $60 million to approximately $40 million. Management highlighted a product roadmap transitioning customers from IRIS sensors to the upcoming HALO sensor package, positioning the company toward profitability through recurring hardware orders.
Innventure: 3 Key Takeaways for Long-Term Investors
Innventure announced a strategic pivot focused on cost reduction and debt restructuring. The company cut parent staff by 62% (from 40 to 15 employees), suspended new development, and stopped funding its operating subsidiaries. Each subsidiary—including liquid-cooling business Accelsius, flexible-packaging developer AeroFlexx, and waste-conversion unit Refinity—must now secure external capital independently. Management hired RBC Capital Markets to evaluate all options including debt restructuring and potential asset monetization.
Maxim Group Analyst Adjusts CXApp Price Target
Maxim Group analyst Jack Vander Aarde maintained a 'Buy' rating on CXApp (CXAI) while lowering the price target from $15 to $8.
MDxHealth Reports Third Quarter 2026 Financial Results
MDxHealth announced its financial results for the third quarter ended September 30, 2026, reporting revenue of $22.7 million and an operating loss of $8.1 million.